Preclinical Insights into the Role of Kir4.1 in Chronic Pain and Depression: Mechanisms and Therapeutic Potential
Biomolecules · 2025
DOI: 10.3390/biom15020165 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, 2025. Verfasst von Tingfeng Zha und 5 weiteren Autor:innen. Beteiligte Einrichtung: Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, …. Hauptthemen laut MEDLINE: Potassium Channels, Inwardly Rectifying, Chronic Pain, Depression. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 191 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key R&D Program of Zhejiang Province, National Natural Science Foundation of China, China Oral Health Foundation.
Themen: Schmerzmanagement, Depression
Abstract (Originalsprache)
Chronic pain and mental health disorders, such as depression and anxiety, frequently co-occur and share underlying mechanisms involving neuronal excitability and synaptic transmission. The inwardly rectifying potassium channel 4.1 (Kir4.1), predominantly expressed in glial cells, is crucial for maintaining extracellular potassium and glutamate homeostasis. Dysregulation of Kir4.1 leads to altered neuronal activity, contributing to both chronic pain and mental health disorders. In chronic pain, downregulation of Kir4.1 impairs potassium buffering and glutamate clearance, increasing neuronal excitability and enhancing pain signaling through peripheral and central sensitization. In mental health disorders, impaired Kir4.1 function disrupts neurotrophic factor secretion and neuroinflammatory pathways, leading to mood disturbances. This review primarily summarizes findings from preclinical studies to examine the relationship between Kir4.1 and the pathogenesis of chronic pain and mental health disorders, discussing its molecular structure, expression patterns, and functional roles. Furthermore, we explore therapeutic strategies targeting Kir4.1, including pharmacological modulators and gene therapy approaches, emphasizing its potential as a novel therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cance…
ORCID-Profile: Jiamin Wan, Jiu Lin
Förderung
- Key R&D Program of Zhejiang Province
- National Natural Science Foundation of China
- China Oral Health Foundation
- Zhejiang Medical and Health Science and Technology Program
- Key R&D Program of Zhejiang Province
Zitieren
APA
Zha, T., Fang, X., Wan, J., Chen, X., Lin, J., & Chen, Q. (2025). Preclinical Insights into the Role of Kir4.1 in Chronic Pain and Depression: Mechanisms and Therapeutic Potential. Biomolecules. https://doi.org/10.3390/biom15020165
Vancouver
Zha T, Fang X, Wan J, Chen X, Lin J, Chen Q. Preclinical Insights into the Role of Kir4.1 in Chronic Pain and Depression: Mechanisms and Therapeutic Potential. Biomolecules. 2025. doi:10.3390/biom15020165
BibTeX
@article{Zha2025,
author = {Zha, Tingfeng and Fang, Xinyi and Wan, Jiamin and Chen, Xiaoyan and Lin, Jiu and Chen, Qianming},
title = {Preclinical Insights into the Role of Kir4.1 in Chronic Pain and Depression: Mechanisms and Therapeutic Potential},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom15020165}
}
EUVIMED